The pathology roadmap in Parkinson disease

Area of Science:

• Neuroscience
• Pathology
• Mitochondrial Biology

Background:

• Parkinson disease (PD) pathogenesis is often linked to dopaminergic neuron loss in the substantia nigra pars compacta (SNc).
• However, early and mid-stage PD reveals Lewy pathology and degeneration in diverse neuronal populations beyond the SNc.
• This broader pathological distribution suggests a more complex disease mechanism.

Purpose of the Study:

• To explore the characteristics of at-risk neuronal populations in Parkinson disease.
• To investigate how these neuronal traits influence susceptibility to proteostatic dysfunction and alpha-synuclein spread.
• To review the literature on these factors and their translational implications for PD.

Main Methods:

• Literature review and synthesis of existing research on Parkinson disease pathogenesis.
• Analysis of neuronal properties associated with pathology distribution in PD.
• Examination of the interplay between neuronal phenotype, mitochondrial function, and alpha-synuclein aggregation.

Main Results:

• Identified a spatially distributed population of neurons vulnerable in PD, sharing specific physiological traits.
• These traits include autonomous activity, broad action potentials, low calcium buffering, and long, unmyelinated axons.
• These features likely increase metabolic burden, potentially driving pathogenesis via mitochondrial deficits and influencing susceptibility to proteostatic stress.

Conclusions:

• The specific phenotype of vulnerable neurons is a critical, under-appreciated factor in Parkinson disease pathogenesis.
• Mitochondrial deficits may be a key driver, exacerbated by neuronal traits that increase metabolic load.
• Understanding these factors is crucial for developing targeted therapies and understanding alpha-synuclein spread.